Lv6
1620 积分 2025-01-05 加入
Cosibelimab: First Approval
1个月前
已完结
Ivonescimab: First Approval
1个月前
已完结
Retifanlimab: First Approval
1个月前
已完结
Envafolimab: First Approval
1个月前
已完结
Cadonilimab: First Approval
1个月前
已完结
Sugemalimab: First Approval
1个月前
已完结
Zimberelimab: First Approval
1个月前
已完结
Dostarlimab: First Approval
1个月前
已完结
Penpulimab: First Approval
1个月前
已完结
Tislelizumab: First Approval
1个月前
已完结